New treatment for blood cancer works by selectively interfering with cancer cell signalling: study (IMAGE)

University of Alberta Faculty of Medicine & Dentistry

New treatment for blood cancer works by selectively interfering with cancer cell signalling: study

Caption

University of Alberta scientist Luc Berthiaume and his team have identified the mechanism of action behind a new type of precision cancer drug for blood cancers. The team plans to soon initiate Phase 1 trials of PCLX-001 in lymphoma, leukemia, breast and colon cancer patients.

Credit

Ryan Parker

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.